Market Place
Sourcing Support
Microbix Product Results Being Presented At 2026 PASCV
27 Apr 2026 //
PHARMIWEB
Microbix Engages with Diagnostics Industry Experts
20 Apr 2026 //
PHARMIWEB
Microbix Presenting At The 2026 Bloom Burton Conference
16 Apr 2026 //
PHARMIWEB
Microbix Exhibiting & Presenting At ESCMID Global 2026
15 Apr 2026 //
PHARMIWEB
Microbix Announces Annual Meeting Voting Results
26 Mar 2026 //
PHARMIWEB
Microbix Announces Issuance Of Stock Options
24 Feb 2026 //
PHARMIWEB
Microbix Reports Results For Q1 2026
12 Feb 2026 //
PHARMIWEB
Microbix Welcomes CAP Pathologists as PT/EQA QAP Client
10 Feb 2026 //
ACCESSWIRE
Microbix Schedules Release Of Results For Q1 Fiscal 2026
05 Feb 2026 //
PHARMIWEB
Microbix Presents Molecular Pathology Platform Results
04 Feb 2026 //
PHARMIWEB
Microbix Updates Investor Presentation On Its Website
09 Jan 2026 //
PHARMIWEB
Microbix Reports Results For Q4 And Fiscal 2025
18 Dec 2025 //
GLOBENEWSWIRE
Microbix Schedules Release Of Results For Q4 Fiscal 2025
11 Dec 2025 //
GLOBENEWSWIRE
Microbix Announces Initiation Of Normal Course Issuer Bid
04 Dec 2025 //
GLOBENEWSWIRE
Microbix Teams Up With SEKISUI For Covid/Flu Test
12 Nov 2025 //
GLOBENEWSWIRE
Microbix Addresses Cybersecurity Incident
05 Nov 2025 //
GLOBENEWSWIRE
Microbix Presenting At Muskoka Capital Event
25 Sep 2025 //
GLOBENEWSWIRE
Microbix Client Labquality Introduces Novel EQA Scheme at ESCV
17 Sep 2025 //
GLOBENEWSWIRE
Microbix Hosts Ontario Minister Stephen Crawford
03 Sep 2025 //
GLOBENEWSWIRE
Microbix Reports Results for Q3 Fiscal 2025
14 Aug 2025 //
GLOBENEWSWIRE
Microbix Schedules Release of Results for Q3 2025 Results Release
07 Aug 2025 //
GLOBENEWSWIRE
Microbix Unveils QUANTDx™ Reference Materials
29 Jul 2025 //
GLOBENEWSWIRE
Microbix Showcases at ADLM Event
24 Jul 2025 //
GLOBENEWSWIRE
Microbix and NCIPD of Bulgaria Sign Supply Deal
08 Jul 2025 //
GLOBENEWSWIRE
Microbix Reports Results for Q2 Fiscal 2025
15 May 2025 //
GLOBENEWSWIRE
Microbix Schedules Release of Results for Q2 Fiscal 2025
08 May 2025 //
GLOBENEWSWIRE
Microbix`s Clot-Buster Drug Project Advances
05 May 2025 //
GLOBENEWSWIRE
Microbix Presenting at the 2025 Bloom Burton Conference
01 May 2025 //
GLOBENEWSWIRE
Microbix Exhibiting at ESCMID Global 2025
09 Apr 2025 //
GLOBENEWSWIRE
Microbix Provides Business Updates
08 Apr 2025 //
GLOBENEWSWIRE
Microbix Announces Annual and Special Meeting Voting Results
27 Mar 2025 //
GLOBENEWSWIRE
Microbix & ACPCC aid Indo-Pacific cervical cancer elimination
17 Mar 2025 //
GLOBENEWSWIRE
Microbix Hosts Ontario Premier Doug Ford & Team
27 Feb 2025 //
GLOBENEWSWIRE
Microbix Announces Issuance of Stock Options
26 Feb 2025 //
GLOBENEWSWIRE
Microbix Reports Strong Revenues & Earnings for Q1 Fiscal 2025
13 Feb 2025 //
GLOBENEWSWIRE
Microbix Schedules Release of Results for Q1 Fiscal 2025
06 Feb 2025 //
GLOBENEWSWIRE
Microbix Receives $2.4 Million from Exercise of Warrants
04 Feb 2025 //
GLOBENEWSWIRE
Microbix & API Ensuring Flu Tests Can Detect H5N1 Strain
13 Jan 2025 //
GLOBENEWSWIRE
Microbix Expands Market With Antigen Tech For Immunoassay Markets
08 Jan 2025 //
GLOBENEWSWIRE
Microbix Reports Record Product Sales for Q4 and Fiscal 2024
19 Dec 2024 //
GLOBENEWSWIRE
Microbix Schedules Release of Results for Q4 Fiscal 2024
12 Dec 2024 //
GLOBENEWSWIRE
Microbix Announces Initiation of Normal Course Issuer Bid
05 Dec 2024 //
GLOBENEWSWIRE
Microbix Presents Novel HSV Test Control at EMMD
07 Oct 2024 //
GLOBENEWSWIRE
Microbix Reports Continued Strong Results for Q3 Fiscal 2024
14 Aug 2024 //
GLOBENEWSWIRE
Microbix Schedules Release of Results for Q3 Fiscal 2024
07 Aug 2024 //
GLOBENEWSWIRE
Microbix Presents HCV FLOQSwab® Format Test Control at ADLM
25 Jul 2024 //
GLOBENEWSWIRE
Microbix Hosts Minister Nina Tangri To Open Capacity Expansions
17 Jun 2024 //
GLOBENEWSWIRE
Microbix Advances Test-Ingredient Manufacturing Capabilities
04 Jun 2024 //
GLOBENEWSWIRE
Microbix Reports Strong Results for Q2 Fiscal 2024
15 May 2024 //
GLOBENEWSWIRE
Microbix Schedules Release of Results for Q2 Fiscal 2024
08 May 2024 //
GLOBENEWSWIRE
Microbix Collaborator Introduces New Lab Accreditation Program
25 Apr 2024 //
GLOBENEWSWIRE
Microbix Presenting at the 2024 Bloom Burton Conference
11 Apr 2024 //
GLOBENEWSWIRE
Microbix Announces Annual and Special Meeting Voting Results
01 Apr 2024 //
GLOBENEWSWIRE
Microbix™s Clot-Buster Drug Project Advances
14 Mar 2024 //
GLOBENEWSWIRE
Microbix Unveils Test Controls for Head and Neck Cancer
11 Mar 2024 //
GLOBENEWSWIRE
Microbix Announces Issuance of Stock Options
26 Feb 2024 //
GLOBENEWSWIRE
Microbix Reports Record Results for Q1 Fiscal 2024
14 Feb 2024 //
GLOBENEWSWIRE
Microbix Schedules Release of Results for Q1 Fiscal 2024
07 Feb 2024 //
GLOBENEWSWIRE
Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen
06 Feb 2024 //
GLOBENEWSWIRE
Microbix Achieves Further QAPs Sales Record
03 Jan 2024 //
GLOBENEWSWIRE
